Oral Contrast Agent For Gastrointestinal Tract Imaging Therapeutics
1. Imagent patent expiration
Treatment: Method of use of imagent
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5798091 | VESSELON SPV | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
Aug, 2015
(10 years ago) | |
| US6280704 | VESSELON SPV | Ultrasonic imaging system utilizing a long-persistence contrast agent |
Jul, 2013
(12 years ago) | |
| US5605673 | VESSELON SPV | Stabilized microbubble compositions for ultrasound |
Feb, 2014
(11 years ago) | |
| US5626833 | VESSELON SPV | Ultrasound imaging method using microbubbles |
May, 2014
(11 years ago) | |
| US5695741 | VESSELON SPV | Stable microbubble precursors |
Dec, 2014
(11 years ago) | |
| US6280705 | VESSELON SPV | Kits & systems for ultrasonic imaging |
Jul, 2013
(12 years ago) | |
| US5639443 | VESSELON SPV | Stabilized microbubble compositions |
Jun, 2014
(11 years ago) | |
| US5720938 | VESSELON SPV | Systems for the formation of microbubbles |
Feb, 2015
(11 years ago) | |
| US6287539 | VESSELON SPV | Methods of imaging using osmotically stabilized microbubble preparations |
Jul, 2013
(12 years ago) | |
Drugs and Companies using DIMYRISTOYL LECITHIN; PERFLEXANE ingredient
Market Authorisation Date: 31 May, 2002
Dosage: INJECTABLE
More Information on Dosage
IMAGENT family patents
